Delivery Order SPE2DB22D2103-SPE2DB25FR9PZ
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a ceiling value of $1,354.88 and an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $1,450.65. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, and involves the delivery of insulin...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,592.90 for NovoLog 100 Unit/mL vials (10 mL) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,809.62 by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Novolog 100 Unit/mL vials (10mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 24, 2025, and represents a child delivery order under a larger contract vehicle. The product will be delivered to the Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $6,072.14. This is a firm fixed-price delivery order issued without set-aside provisions, indicating competitive award to a qualified vendor. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery...
- The Defense Logistics Agency awarded a $2,726.60 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for NovoLog 100 Unit/mL vials (10 mL) with a completion date of August 4, 2025. This firm fixed price delivery order, which represents a non-set-aside competitive award, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,749.33 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions. The contract calls for performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL) under a firm fixed-price contract with a ceiling value of $1,210.78. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is structured as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.69 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). The award is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency awarded a delivery order valued at $3,076.79 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of July 31, 2025. No...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9PZDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). The contract is valued at $4,826.10 with a firm fixed price structure and completion targeted for August 1, 2025. This is a non-set-aside competitive award, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle that runs through December 2026 and serves as the primary global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for the federal government, supplying medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. As the prime contractor on this delivery order, AmerisourceBergen leverages its established relationship with DLA to provide essential diabetes management medications and other pharmaceutical products. The DLA Medical Supply Chain procurement strategy includes plans for the Pharmaceutical Prime Vendor Global Program Generation V, which will involve multiple regional awards among several contractors, positioning AmerisourceBergen within a competitive vendor ecosystem designed to ensure robust pharmaceutical supply availability for military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 7/31/25 |